Klara Balint
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 30, 2020
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
Journal: Journal of translational medicine
Published: September 12, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients.
Journal: Frontiers in immunology
Published: April 29, 2019
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results.
Journal: Frontiers in immunology
Published: August 14, 2018
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy.
Journal: Oncoimmunology
Published: April 26, 2017
Potential approaches for more successful dendritic cell-based immunotherapy.
Journal: Expert opinion on biological therapy
Published: January 03, 2015
Immunotherapy for ovarian cancer: recent advances and perspectives.
Journal: Current opinion in oncology
Published: July 19, 2014
Ionizing radiation selectively reduces skin regulatory T cells and alters immune function.
Journal: PloS one
Published: March 11, 2014
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
Journal: Journal of translational medicine
Published: April 17, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026